Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin E2 receptor EP2 (EP2) is a G protein-coupled receptor (GPCR) that binds prostaglandin E2 (PGE2). It is encoded by the PTGER2 gene and is widely distributed throughout the body, mediating diverse biological effects through cAMP signaling and β-arrestin pathways. EP2 is involved in inflammation, cancer, and other pathological processes and is considered a therapeutic target for drug discovery.
Activation by PGE2 stimulates adenylate cyclase, increasing cAMP levels and activating PKA or Epac pathways. Can also signal through β-arrestin pathways activating JNK or ERK kinases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E2 receptor EP2 (EP2).